ReviewJournal of nanobiotechnology2026
Integrating silver nanomaterials in wound healing: from physicochemical properties to clinical translation.
Review in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wound healing is a complex process that involves the interplay of infection, inflammation, and tissue regeneration. Nevertheless, the conventional therapies tend to treat these processes individually. Silver nanomaterials have been found to serve as platforms for surface chemistry and controlled ion-release kinetics, conferring a wide array of biological activities beyond their traditional antimicrobial applications and making them promising therapeutic platforms with broad-spectrum antimicrobial, immunomodulatory, and regenerative properties. Their versatile physicochemical properties, such as size and morphology. This review provides a critical, detailed examination of the biological processes that determine the therapeutic effects of silver nanomaterials, as well as their design principles and physicochemical properties. We discuss their multi-target antimicrobial effects against bacterial, fungal, and viral infections, as well as their role in regulating innate and adaptive immunity during wound healing, including in biofilm infections. These materials, along with soft-tissue and internal-organ repair, are discussed in both cutaneous and non-cutaneous applications, as well as in orthopedic and dental applications. Moreover, the most significant translational considerations, such as safety, dose-dependent toxicity, biodistribution, the long-term fate, and regulatory factors, are critically examined. The review highlights the importance of drawing on insights from materials science, microbiology, immunology, and regenerative medicine to demonstrate how rationally designed silver nanomaterials can address unmet clinical needs and identify opportunities for their safe and effective clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.